Daniel's research focuses on employing organ on a chip technology to study the interaction between the immune system and the microbiome in gastrointestinal diseases. His previous experience includes the evaluation of combinatorial immunotherapies and nanotherapeutics for cancer treatment, the development of microfluidic devices for studying bacterial physiology, and the optimization of in vitro models of healthy and pathological tissues.
